Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
We conclude that endocannabinoids tonically suppress cardiac contractility in hypertension and that enhancing the CB1-mediated cardiodepressor and vasodilator effects of endogenous anandamide by blocking its hydrolysis can normalize blood pressure. Targeting the endocannabinoid system offers novel therapeutic strategies in the treatment of hypertension.
(PMID: 15451779 [PubMed - indexed for MEDLINE] PMCID: PMC2756479 )
This Research and Resources page is sponsored by the Ohio Rights Group Education Fund.
Please support our charitable and educational work by making a generous tax deductible donation.